Evaluation: Body fat (DXA scanning) Lean mass Insulin sensitivity Energy expenditure What they found: The combination showed an additive effect on fat reduction vs monotherapy AOD-9604 partially protected lean mass during GLP-1-induced weight reduction Increased energy expenditure in combination (~3 % vs GLP-1 alone) No new safety signals Why it matters: It validates the concept of combination , the idea that AOD-9604 may not work on its own, but can add value in combination with incretin agonists
But like any peptide, your results hinge on how much you take, how often, and for how long
For example, if the desired dose is 250 mcg: Required volume = Desired dose Concentration 250 mcg 500 mcg/mL = 0.5 mL In this example, 0.5 mL of solution contains 250 mcg of peptide
Kumar A, Palfrey HA, Pathak R et al
Use this table as a starting reference, then adjust based on how your injury responds over the first 2 weeks